Literature DB >> 23266102

Associations of urinary 6-sulfatoxymelatonin with demographics, body mass, sex steroids, and lifestyle factors in preschool Japanese children.

Keiko Wada1, Kozue Nakamura, Yuya Tamai, Michiko Tsuji, Takako Masue, Kaori Watanabe, Kyoko Ando, Chisato Nagata.   

Abstract

PURPOSE: We aimed to assess the associations of sex, age, body mass, sex steroid hormones, and lifestyle factors with the levels of melatonin in young children.
METHODS: This study followed a cross-sectional design and was conducted two preschools in Japan. Subjects were 235 boys and 203 girls, aged 3-6 years. Information related to demographics, body mass, and lifestyle factors was obtained from parent-administered questionnaires. The levels of 6-sulfatoxymelatonin and dehydroepiandrosterone in first-void morning urine were measured by radioimmunoassay. Urinary estrone, estradiol, testosterone, and 5-androstene-3β, 17α diol levels were measured by liquid chromatography-electrospray ionization tandem mass spectrometry.
RESULTS: The creatinine-corrected 6-sulfatoxymelatonin levels and the estimated value of 6-sulfatoxymelatonin excretion were higher in girls than in boys. After adjustments for age, the creatinine-corrected 6-sulfatoxymelatonin was negatively associated with weight and body mass index among boys and with weight and height among girls. However, the estimated value of 6-sulfatoxymelatonin excretion was not associated with any indices of body mass. No significant relationships of urinary sex steroids, light exposure at night, sleep time, sedentary lifestyles, or passive smoking with urinary 6-sulfatoxymelatonin were observed.
CONCLUSIONS: Our findings suggest that melatonin levels depend on sex and body size among young healthy children. Our results should be confirmed in future researches.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266102     DOI: 10.1016/j.annepidem.2012.11.003

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  4 in total

1.  Serum melatonin levels are associated with mortality in patients with malignant middle cerebral artery infarction.

Authors:  Leonardo Lorente; María M Martín; Pedro Abreu-González; Antonia Pérez-Cejas; Luis Ramos; Mónica Argueso; Jordi Solé-Violán; Juan J Cáceres; Alejandro Jiménez; Victor García-Marín
Journal:  J Int Med Res       Date:  2018-05-30       Impact factor: 1.671

2.  Interactions between nocturnal melatonin secretion, metabolism, and sleeping behavior in adolescents with obesity.

Authors:  Johanna Overberg; Laura Kalveram; Theresa Keller; Heiko Krude; Peter Kühnen; Susanna Wiegand
Journal:  Int J Obes (Lond)       Date:  2022-02-09       Impact factor: 5.551

3.  Individual variations in serum melatonin levels through time: implications for epidemiologic studies.

Authors:  Leticia M Nogueira; Joshua N Sampson; Lisa W Chu; Kai Yu; Gerald Andriole; Timothy Church; Frank Z Stanczyk; Jill Koshiol; Ann W Hsing
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

4.  Sleep-wake rhythm disruption is associated with cancer-related fatigue in pediatric acute lymphoblastic leukemia.

Authors:  Lindsay M H Steur; Gertjan J L Kaspers; Eus J W Van Someren; Natasha K A Van Eijkelenburg; Inge M Van der Sluis; Natasja Dors; Cor Van den Bos; Wim J E Tissing; Martha A Grootenhuis; Raphaële R L Van Litsenburg
Journal:  Sleep       Date:  2020-06-15       Impact factor: 5.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.